Duke University: Breast Neoplasms trials

The registry lists 54 Breast Neoplasms studies with Duke University as lead sponsor. 6 are open to participants now and 13 have results posted.

Phase 1 8Phase 2 13No phase 35(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Radiation Therapy and Thymus Function in Young Women With Breast CancerRecruitingNCT07725172
• ORASIS in Breast ReconstructionNot yet recruitingNCT07670754Not applicable
• Weight Management After Cancer for Survivors in Rural CommunitiesRecruitingNCT07426952Not applicable
• Geriatric Oncology Assessment and Coping Skills Training for Older Women on Aromatase Inhibitor TherapyNot yet recruitingNCT07232056Not applicable
• Planning Grant for TOPS for Breast Cancer SurvivorsRecruitingNCT06658912Not applicable
• Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer SurvivorsRecruitingNCT06371768Not applicable
• TOPS for African American Breast Cancer SurvivorsCompletedNCT04741802Not applicableResults posted
• mHealth Behavioral Cancer Pain Intervention for Medically Underserved PatientsCompletedNCT04175639Not applicableResults posted
• Symptom Management for YA Cancer SurvivorsCompletedNCT04035447Not applicableResults posted
• Promoting Breast Cancer Screening in Women Who Survived Childhood CancerCompletedNCT03435380Not applicableResults posted
• Phase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA)CompletedNCT03167619Phase 2Results posted
• Diagnostic Utility of MRI in Female Patients With Nipple Discharge: A Prospective TrialTerminatedNCT02818946Not applicableResults posted
• Preoperative Single-Fraction Radiotherapy in Early Stage Breast CancerActive, not recruitingNCT02482376Phase 2Results posted
• Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast CancerTerminatedNCT01207102Phase 2Results posted
• Single Dose Partial Breast RadiotherapyCompletedNCT00944528Phase 1Results posted
• Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast CancerTerminatedNCT00636441Phase 2Results posted
• Phase II Dasatinib Study in Advanced Breast CancerCompletedNCT00546104Phase 2Results posted
• Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast CancerCompletedNCT00479674Phase 2Results posted
• A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to BrainTerminatedNCT00476827Phase 2Results posted
• Adaptation and Pilot Testing of a Mindfulness-Based Insomnia and Symptom Management Intervention for Women With Breast Cancer Receiving Treatment in Rural Medically Underserved AreasCompletedNCT06529120Not applicable
• Cardiac Outcomes With Near-Complete Estrogen DeprivationActive, not recruitingNCT05309655Not applicable
• The Effect of Intermittent Fasting on Body Composition in Women With Breast CancerWithdrawnNCT04691999Not applicable
• A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast CancerTerminatedNCT04655573
• Exercise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Breast Conservation Therapy for Women With Early Stage Breast CancerWithdrawnNCT04449809Not applicable
• Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast CancerCompletedNCT04352777Phase 2
• Onco-primary Care Networking to Support TEAM-based CareActive, not recruitingNCT04258813Not applicable
• Hypertension Management in Cancer PatientsTerminatedNCT03919214Not applicable
• Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast CancerCompletedNCT03719495
• Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBCWithdrawnNCT03045393Phase 1
• Four Conversations RCTCompletedNCT02944344Not applicable
• ICAN Symptoms Duke-NUSCompletedNCT02787993Not applicable
• HER2+ Breast Cancer Neo-Adjuvant Coordination of Care ProgramCompletedNCT02616133
• Behavioral Weight and Symptom Management for Breast Cancer Survivors and PartnersCompletedNCT02574507Not applicable
• Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine TherapyWithdrawnNCT02483871Phase 1
• Improving Adherence to Recommended Surveillance in Breast Cancer SurvivorsCompletedNCT02189278Not applicable
• Self-Reported Exercise Behavior and Short-Term Patient Outcomes in Women Undergoing Radiation Treatment for Operable Breast CancerCompletedNCT02050620
• Self-management Interventions for Advanced Breast CancerCompletedNCT01927081Not applicable
• Enhancing Exercise in Breast Cancer SurvivorsCompletedNCT01849978Not applicable
• A Novel Optical Spectral Imaging System for Imaging Breast Tumor MarginsCompletedNCT01372631Not applicable
• Fast Spectral Imaging Device for Tumor Margin MappingCompletedNCT01107080
• Optical Spectroscopy During Breast Cancer Surgery and Core Needle BiopsyCompletedNCT00734838Not applicable
• Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of DiseaseCompletedNCT00674791Phase 1
• Early Detection of Breast Cancer Using Tomosynthesis ImagingCompletedNCT00637598Not applicable
• DAMES: Daughters And MothErS Against Breast CancerCompletedNCT00630591Not applicable
• Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy.CompletedNCT00405678Phase 1/2
• Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast CancerTerminatedNCT00346229Phase 1
• Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are OverweightCompletedNCT00303875Phase 2
• Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBCCompletedNCT00134680Phase 2
• A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly PaclitaxelCompletedNCT00131963
• Survival TRaining for ENhancing Total Health (STRENGTH)CompletedNCT00068458Phase 2
• Study of Health Promotion in Patients With Early-Stage Breast or Prostate CancerCompletedNCT00037024Not applicable
• Biological Therapy in Treating Patients With Advanced CancerCompletedNCT00005956Not applicable
• Biological Therapy in Treating Patients With Metastatic CancerCompletedNCT00004604Phase 1
• Immunotherapy in Treating Patients With Metastatic Breast CancerTerminatedNCT00003432Phase 1/2